
News|Articles|March 15, 2024
Results: MHE Question of the Week About Medicare Cap Extension
Author(s)MHE Staff
The results of this week’s poll about Medicare cap extension.
Advertisement
The results are in and 75% of our readers think the Medicare $2,000 per-year cap on out-of-pocket costs for prescription drugs should not be extended to commercial insurance.
A $3,250 cap went into effect this year and will be lowered to $2,000 next year. At this time, it only applies to Medicare enrollees with Part D coverage.
We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answer and post the results on Friday.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Will the end of enhanced ACA subsidies mean the beginning of a health insurance crisis?
2
Pharmacy leaders in ASHP survey worry about 340B program changes
3
FDA approves first postmenopausal libido treatment, Addyi
4
Many PCPs unaware of current ACIP shingles vaccine guidance, study finds
5


















































